P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,334.05
173.15 (3.36%)
BSENSE

May 06

BSE+NSE Vol: 21.97 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Dec'24
Sep'24
Dec'23
Dec'22
Dec'21
Dec'20
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 11.11%

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 56.11%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 29.77%

stock-summary

Interest

Growth in half year ended Sep 2025 is -31.43%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
663.66
640.18
23.48
3.67%
Other Operating Income
0.00
0.00
0.00
Total Operating income
663.66
640.18
23.48
3.67%
Raw Material Cost
137.67
291.94
-154.27
-52.84%
Purchase of Finished goods
34.95
43.78
-8.83
-20.17%
(Increase) / Decrease In Stocks
-10.23
-5.46
-4.77
-87.36%
Employee Cost
109.89
56.36
53.53
94.98%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
180.77
111.43
69.34
62.23%
Total Expenditure (Excl Depreciation)
453.05
498.05
-45.00
-9.04%
Operating Profit (PBDIT) excl Other Income
210.61
142.13
68.48
48.18%
Other Income
8.98
60.20
-51.22
-85.08%
Operating Profit (PBDIT)
219.59
202.33
17.26
8.53%
Interest
0.24
0.62
-0.38
-61.29%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
219.35
201.71
17.64
8.75%
Depreciation
11.52
16.64
-5.12
-30.77%
Profit Before Tax
207.83
185.07
22.76
12.30%
Tax
53.11
37.21
15.90
42.73%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
154.72
147.86
6.86
4.64%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
154.72
147.86
6.86
4.64%
Equity Capital
16.60
45.32
-28.72
-63.37%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
93.20
3.26
89.94
2,758.90%
Diluted Earnings per share
93.21
3.26
89.95
2,759.20%
Operating Profit Margin (Excl OI)
31.73%
22.20%
0.00
9.53%
Gross Profit Margin
33.05%
31.51%
0.00
1.54%
PAT Margin
23.31%
23.10%
0.00
0.21%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 663.66 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 11.11%

Half Yearly - Standalone Net Profit
Standalone Net Profit 154.72 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 56.11%

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 210.61 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 29.77%

Half Yearly - Interest
Interest 0.24 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -31.43%

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.73%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024